Literature DB >> 28078726

Dissecting the Cytochrome P450 1A2- and 3A4-Mediated Metabolism of Aflatoxin B1 in Ligand and Protein Contributions.

Silvia Bonomo1, Flemming Steen Jørgensen1, Lars Olsen1.   

Abstract

Aflatoxin B1 (AFB1) is a chemically intriguing compound because it has several potential sites of metabolism (SOMs), although only some of them are observed experimentally. Cytochrome P450 (CYP) 3A4 and 1A2 are the major isoforms involved in its metabolism. Here, we systematically investigate reactivity and accessibility of all possible SOMs in these two CYPs to elucidate AFB1 metabolism. DFT calculations were used to determine activation energies for each possible reaction. Aliphatic hydroxylation on position 9A and 3α are energetically favored, whereas position 9 is the preferred site for epoxidation. Docking studies, molecular dynamics (MD) simulations, and free energy (MM/GBSA) calculations were applied to elucidate the accessibility of each SOM. The most stable binding modes in CYP3A4 favor the formation of the 3α-hydroxylated and 8,9-exo-epoxide metabolites. Conversion of the methoxy group is also sterically possible, but not observed experimentally due to its low reactivity. In the CYP1A2 active site, AFB1 cannot orient position 3 towards the catalytic center, whereas the 8,9-exo-epoxide and 9A-hydroxylated metabolites are formed from the most stable and the 8,9-endo-epoxide from a less stable binding mode, respectively. The results agree with experimental data and suggest that both reactivity and the shape of the enzyme active site need to be considered to understand the distribution of SOMs and to improve current SOM prediction methods.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  aflatoxin b1; computational chemistry; cytochrome p450; density functional theory; metabolism

Year:  2017        PMID: 28078726     DOI: 10.1002/chem.201605094

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.

Authors:  Mei-Hui Hsu; Uzen Savas; Eric F Johnson
Journal:  Mol Pharmacol       Date:  2017-11-01       Impact factor: 4.436

2.  Computational Insight Into Vitamin K1 ω-Hydroxylation by Cytochrome P450 4F2.

Authors:  Junhao Li; Hongxiao Zhang; Guixia Liu; Yun Tang; Yaoquan Tu; Weihua Li
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

3.  Fluorescence Spectroscopic Investigation of Competitive Interactions between Quercetin and Aflatoxin B₁ for Binding to Human Serum Albumin.

Authors:  Hongxia Tan; Lu Chen; Liang Ma; Shuang Liu; Hongyuan Zhou; Yuhao Zhang; Ting Guo; Wei Liu; Hongjie Dai; Yong Yu
Journal:  Toxins (Basel)       Date:  2019-04-09       Impact factor: 4.546

4.  Multiple CH/π Interactions Maintain the Binding of Aflatoxin B₁ in the Active Cavity of Human Cytochrome P450 1A2.

Authors:  Jun Wu; Sisi Zhu; Yunbo Wu; Tianqing Jiang; Lingling Wang; Jun Jiang; Jikai Wen; Yiqun Deng
Journal:  Toxins (Basel)       Date:  2019-03-12       Impact factor: 4.546

5.  Thinking Out of the Box: On the Ability of Zea mays L. to Biotrasform Aflatoxin B1 Into Its Modified Forms.

Authors:  Laura Righetti; Enrico Rolli; Luca Dellafiora; Gianni Galaverna; Michele Suman; Renato Bruni; Chiara Dall'Asta
Journal:  Front Plant Sci       Date:  2021-01-12       Impact factor: 5.753

6.  Mechanistic Insights into the Regio- and Stereoselectivities of Testosterone and Dihydrotestosterone Hydroxylation Catalyzed by CYP3A4 and CYP19A1.

Authors:  Junhao Li; Yun Tang; Weihua Li; Yaoquan Tu
Journal:  Chemistry       Date:  2020-04-28       Impact factor: 5.236

7.  The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.

Authors:  Yu-Yan Pang; Jian-Di Li; Li Gao; Xia Yang; Yi-Wu Dang; Ze-Feng Lai; Li-Min Liu; Jie Yang; Hua-Yu Wu; Rong-Quan He; Zhi-Guang Huang; Dan-Dan Xiong; Li-Hua Yang; Lin Shi; Wei-Jia Mo; Deng Tang; Hui-Ping Lu; Gang Chen
Journal:  Cancer Med       Date:  2020-09-15       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.